Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01776983
Other study ID # 2008SIA01
Secondary ID
Status Completed
Phase Phase 4
First received January 24, 2013
Last updated June 15, 2015
Start date September 2008
Est. completion date January 2014

Study information

Verified date June 2015
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy. Immunocompromised patients (for more than seven years) compared to immunocompetent patients.

- Trial in the field of transplantation / xenotransplantation


Description:

Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy. Immunocompromised patients (for more than seven years) compared to immunocompetent patients.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date January 2014
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion criteria:

- Renal transplant recipients transplanted more than seven years ago and immunocompetent probands of the same age.

Exclusion criteria:

- Refusal of informed consent, physical or psychological inability to give informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Photosensitivity under the influence of immunocomp
Siascopy measurement of reflected light

Locations

Country Name City State
Switzerland University Hospital Zurich, Department of Dermatology Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

References & Publications (1)

Stimpfle DW, Serra AL, Wüthrich RP, French LE, Braun RP, Hofbauer GF. Spectophotometric intracutaneous analysis: an investigation on photodamaged skin of immunocompromised patients. J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1141-7. doi: 10.1111/jdv.127 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary skin aging defined by melanin, collagen and hemoglobin content there is only one time point for measurement, there is no "time frame", just one single measurement per patient at the one and only visit One Time measurement at the one and only time point of inclusion and measurement
See also
  Status Clinical Trial Phase
Completed NCT01491620 - Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte N/A
Completed NCT00204542 - Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head Phase 4
Recruiting NCT02904564 - Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation Phase 4